Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Squamous Cell Carcinoma of the Head and Neck (SCCHN)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01927744
What this trial is testing

Study of Chemotherapy With Cisplatin/Carboplatin, and Docetaxel With or Without Erlotinib in Patients With Head and Neck Squamous Cell Carcinomas Amenable for Surgical Resection

Who this might be right for
Head and Neck Cancer
M.D. Anderson Cancer Center 55
Large-scale testing (Phase 3)Ended earlyNCT05930938
What this trial is testing

Study Comparing RT With Cetuximab + Xevinapant to RT With Cetuximab-placebo in Patients With Head and Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Groupe Oncologie Radiotherapie Tete et Cou 19
Testing effectiveness (Phase 2)Ended earlyNCT03277352
What this trial is testing

INCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies

Who this might be right for
Advanced MalignanciesMetastatic Cancer
Incyte Biosciences International Sàrl 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT04183166
What this trial is testing

A Clinical Trial Evaluating TG4050 in Head and Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Transgene 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT03468218
What this trial is testing

Pembrolizumab & Cabozantinib in Patients With Head and Neck Squamous Cell Cancer

Who this might be right for
Metastatic Head and Neck CarcinomaParanasal Sinus Squamous Cell CarcinomaRecurrent Head and Neck Squamous Cell Carcinoma+21 more
Emory University 36
Large-scale testing (Phase 3)WithdrawnNCT00363441
What this trial is testing

Conventional 3D Radiation vs. Intensity-Modulated Radiation in Squamous Cell Cancer of the Head and Neck

Who this might be right for
Head and Neck NeoplasmsSquamous Cell Cancer
Alberta Health services
Large-scale testing (Phase 3)Study completedNCT01177956
What this trial is testing

A Trial to Determine the Safety and Anti-tumor Activity Profile of the Combination of Cetuximab and Concomitant Cisplatin Plus 5-Fluorouracil (5-FU) in Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma in Head and Neck

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Merck KGaA, Darmstadt, Germany 73
Testing effectiveness (Phase 2)Ended earlyNCT00392665
What this trial is testing

Bevacizumab/Tarceva and Tarceva/Sulindac in Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Massachusetts General Hospital 36
Early research (Phase 1)Study completedNCT01911598
What this trial is testing

MEHD7945A in Combination With Cisplatin and 5-Fluorouracil (5-FU) or Paclitaxel and Carboplatin in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN)

Who this might be right for
Head and Neck Cancer
Genentech, Inc. 24
Testing effectiveness (Phase 2)WithdrawnNCT05359692
What this trial is testing

INCAGN01876 in Combination With Immunotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Metastatic Head and Neck Squamous Cell CarcinomaAdvanced MalignanciesRecurrent Head and Neck Squamous Cell Carcinoma
Incyte Biosciences International Sàrl
Testing effectiveness (Phase 2)Study completedNCT00705016
What this trial is testing

Cilengitide in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Who this might be right for
Squamous Cell Cancer
Merck KGaA, Darmstadt, Germany 184
Large-scale testing (Phase 3)Study completedNCT02741570
What this trial is testing

Study of Nivolumab in Combination With Ipilimumab Compared to the Standard of Care (Extreme Regimen) as First Line Treatment in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Cancer
Bristol-Myers Squibb 947
Testing effectiveness (Phase 2)Study completedNCT00004070
What this trial is testing

Gene Therapy in Treating Patients With Unresectable, Recurrent, or Refractory Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Dana-Farber Cancer Institute 7
Testing effectiveness (Phase 2)Study completedNCT02001623
What this trial is testing

Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors

Who this might be right for
Ovary CancerCervix CancerEndometrium Cancer+5 more
Seagen Inc. 195
Testing effectiveness (Phase 2)Study completedNCT00095927
What this trial is testing

Randomized Amifostine For SCCHN

Who this might be right for
Chemotherapeutic Agent ToxicityHead and Neck CancerMucositis+2 more
Dana-Farber Cancer Institute 58
Early research (Phase 1)Study completedNCT03129061
What this trial is testing

Study to Evaluate Immunological Response to PD-1 Inhibition in Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
CellSight Technologies, Inc. 15
Early research (Phase 1)Looking for participantsNCT06736379
What this trial is testing

Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer

Who this might be right for
Head and Neck Cancers- Squamous CellHead and Neck CancerSolid Tumors+10 more
VLP Therapeutics 41
Testing effectiveness (Phase 2)Ended earlyNCT01794845
What this trial is testing

Cetuximab + Taxotere With Low Dose Fractionated Radiation for Head and Neck Carcinoma

Who this might be right for
Squamous Cell CarcinomaHead and Neck CancerRecurrent Disease
University of Miami 5
Early research (Phase 1)Study completedNCT02381535
What this trial is testing

Onalespib in Treating Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck Receiving Radiation Therapy and Cisplatin

Who this might be right for
Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7+9 more
National Cancer Institute (NCI) 2
Testing effectiveness (Phase 2)Study completedNCT04107103
What this trial is testing

Nivolumab Plus Pemetrexed for Head and Neck Squamous Cell Carcinoma

Who this might be right for
SCCHN
AHS Cancer Control Alberta 6
Next Page